Kies je regio

Selecteer de regio die het beste past bij je locatie of voorkeuren.

International

Kies je sitetaal

Deze instelling regelt de taal van de gebruikersinterface, inclusief knoppen, menu's en alle tekst op de site. Selecteer je voorkeurstaal voor de beste browse-ervaring.

Kies de talen voor vacatures

Selecteer de talen voor vacatures die je wilt zien. Deze instelling bepaalt welke vacatures aan jou worden getoond.

qSTAR Medical

Parijs, Frankrijk

Maak een e-mailalert aan

Website bezoeken

Over de werkgever

qSTAR Medical aims to improve the lives of patients suffering from End Stage Renal Disease (ESRD) by developing an innovative vascular access device featuring STAR® Biomaterial.

qSTAR Medical SAS was established in late 2011 as a spinout of Healionics USA with the support of OSEO France to develop a needle-free percutaneous port system for improved, pain-free and cost-effective vascular access for hemodialysis (HD) therapy.

There are approximately 20 million patients worldwide who suffer from Chronic Kidney Disease (CKD). An estimated 10% of these patients (2m) have progressed to the severe loss of kidney function defined as End Stage Renal Disease (ESRD) which requires life-sustaining thrice-weekly or daily dialysis therapy. Vascular access is the "Achilles heel" of hemodialysis therapy due to its high complication rates. ESRD patients need and deserve better vascular access options – qSTAR was created to help.